... seriousness of the neoplastic diseases being treated by IFNs, the risks involved are, in my opinion, not strong enough to prevent the use of natural IFN preparations Furthermore, human leukocyte IFN-a has ... IU per mouse The injections were made S.C around the tumor or intratumorally (ik.) They saw a stronger anti-tumor effect with the i.t injections Several of the tumors tested were sensitive to ... EFFECTS 37 lines The effects, if present, were weak When targets were superinfected with EBV, the strongest lytic reactions were obtained with IFN-treated lymphocytes In 1980, Masucci et al (1980a)...
... social world À from the perspective of the individual’s well-being Emotions are ineluctable and strongly embodied, thus closely geared to action Emotions register forcibly, both as communications...
... distance walked” (p=0.036 and 0.002 respectively) as compared to G+C treated group There was as a strong trend toward UC-II efficacy UC-II treatment effectively reduced Lequesne’s functional index...
... regarding the femoral part In the literature, the dislocation rates after hip spacer implantation may strongly vary depending on the art of the spacer’s production as well as the fixation method Leunig ... the glycopeptide generates the nephrotoxic effect The time of ARF manifestation might also vary strongly among the reported cases without having any precise explanation for this discrepancy Until...
... therapy is changed from viral cure to prevention of disease progression Clearly, treatment is strongly indicated with early cirrhosis without decompensation as progression will occur in the majority ... 12 months with a 50% SVR Those people with viral suppression during treatment may benefit from stronger and longer treatment [5] Table shows the SVR in re-treatment of patients who were non-responders ... some trials now define non-responder as early as 12 or even weeks modifying treatment with either stronger treatment or longer treatment to try to produce a better SVR [7, 32] Longer treatment Kinetic...